Skip to main content
Clinical Trials/IRCT20170903036041N1
IRCT20170903036041N1RecruitingPhase 2

Evaluation of Effectiveness of Different Dosage of Neostigmine in Combination with Metoclopramide, on Gastric Residual Volume, in Enteral Nutrition, in Hospitalized Patients in Intensive Care Unit

Vice chancellery for research Iran University of Medical Sciences0 sites165 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
165

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Enteral nutrition feeding
  • After three hours from the last gavage gastric residual volume =50%

Exclusion Criteria

  • Diabetes mellitus disease
  • Atrioventricular block
  • Heart rate <60
  • Systolic blood pressure <90
  • Within 10 days Gastrointestinal surgery
  • Clinical signs of Gastrointestinal obstruction
  • Bronchospasm or Asthma history
  • In 24 hours administration of Prokinetic drugs
  • Sensitivity to Metoclopramide or Neostigmine
  • Kidney failure or Creatinine >2 milligram/deciliter
  • Hypokalemia
  • Concomitant medication with Cyclosporine
  • Digoxin and Monoamine Oxidase inhibitors

Investigators

Sponsor
Vice chancellery for research Iran University of Medical Sciences

Similar Trials